Cargando…
Understanding Barriers to Oral Therapy Adherence in Adults With Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a disease of older adults, with a median age at diagnosis of 68 years. The availability of oral anticancer medications has increased, although the standard treatment for AML remains in intravenous form. We aim to identify barriers to adherence to oral medications in p...
Autores principales: | Bryant, Ashley Leak, Chan, Ya-Ning, Richardson, Jaime, Foster, Matthew, Owenby, Susie, Wujcik, Debra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863126/ https://www.ncbi.nlm.nih.gov/pubmed/33604095 http://dx.doi.org/10.6004/jadpro.2020.11.4.2 |
Ejemplares similares
-
A Pharmacist-Led Oral Chemotherapy Program's Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes
por: Dennison, Taylor, et al.
Publicado: (2021) -
Shared Decision-Making in Managing Breakthrough Cancer Pain in Patients With Advanced Cancer
por: Brant, Jeannine M., et al.
Publicado: (2022) -
Impact of Adherence to Ibrutinib on Clinical Outcomes in Real-World Patients With Chronic Lymphocytic Leukemia
por: Garner, Lauren M., et al.
Publicado: (2021) -
Research Strategy for the Development of a Quality-of-Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia
por: Tinsley-vance, Sara M.
Publicado: (2023) -
Understanding Attitudes and Roles of Oncology Advanced Practitioners in the Setting of Cancer Clinical Trials: A Pilot Study
por: Braun-inglis, Christa, et al.
Publicado: (2021)